© 2025 Actimo Labs Pty Ltd. All rights reserved.
Trusted by industry and academic professionals
480 hrs+
Time savings
87%
of Wet-Lab Cost
Why ActiMap?
Sequence & Structure Only Inputs
No wet lab required.
ActiMap only requires antibody sequences & antigen structure data, enabling in silico analysis without physical samples. Ideal for early-stage R&D and hard-to-source targets.
Fast, High Throughput Predictions
Don't wait months for results.
We accelerate discovery and development through our high-throughput capabilties, offering high resolution structural insights of antibody candidates.
De-Risk Candidates with AI Confidence Scores
Move forward with confidence.
ActiMap assigns a confidence score to each residue in the target - on par with wet-lab procedures, book a demo to view more data insights about our screening process.
IP Strategy & Competitive Advantage
Move quicker with more data.
Use ActiMap to generate early insights that support novel epitope claims and strengthen patent filings, giving your programs a defensible edge from day one.
Frequently Asked Questions
Have questions about how we can accelerate your antibody's preclinical development? Explore our FAQs below for quick answers.
How does ActiMap work?
By using your sequence and structure data, we will annotate your antibody, map the residues on the antibody and the antigen.
What inputs are required to run ActiMap?
ActiMap requires only the protein sequences of the antibody (either FASTA or txt format) and the antigen structure (either PDB or mmCIF format). No expression systems are needed.
How can I engage with your services now?
Book a demo with our team who will conduct an onboarding call to understand your needs and ensure our deliverables with your needs. From here we will send you a completed report
If you are a clinical researcher or computational biologist who could benefit from our services, please reach out to us to discuss how we can help your antibody get to market quicker.
At what stage of the drug discovery process is epitope mapping most useful?
Traditionally used in late-stage lead characterization, ActiMap enables epitope mapping much earlier during screening and selection, helping to prioritize leads, identify liabilities, and support IP claims sooner.
Still have a question?
Speak to a member of our team below.